The growth for Brain disorders diagnostics is anticipated to reach US$12,162.6 million in 2019 and grow at a7.6% CAGR during the forecast period (2019–2027). Tools for diagnosing neurological disorders include medical equipment for conditions like Alzheimer's disease (AD), Parkinson's disease (PD), and multiple sclerosis. Imaging tools like computed tomography (CT), magnetic reason acne imaging (MRI), and in vitro diagnostic tools like biomarkers and biopsy are among the devices that are primarily used in diagnosis. The need for diagnostic tools has increased recently due to an increase in the prevalence of neurological disorders. For instance, the Alzheimer's Association reported in 2018 that 5.7 million Americans across all age groups experienced dementia and Alzheimer's in 2017.
All accepted abstracts will be published in respective Allied Academies Journals.
Abstracts will be provided with Digital Object Identifier by
